Immunome Inc.

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	4	+246K	93.2%	$11.48	+$2.82M
Sells	2	-17.9K	6.8%	$15.60	-$279K
Net	+2	+228K	86.4%		+$2.54M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Isaac Barchas	Director	$16.7M			Jun 13, 2024
Michael Rapp	Director	$7.56M			Oct 2, 2023
Clay B. Siegall	President and CEO, Director	$5.08M	+$2.35M	+86.1%	Nov 21, 2024
Max Rosett	Chief Financial Officer	$760K	-$230K	-23.2%	Sep 19, 2024
Franklyn G. Prendergast	Director	$360K			Oct 2, 2023
Bruce Turner	Chief Strategy Officer	$250K			Aug 9, 2024
Jean Jacques Bienaime	Director	$232K	+$125K	+117%	Aug 15, 2024
Philip Tsai	Chief Technology Officer	$198K	+$198K		Nov 21, 2024
Jack Higgins	Chief Scientific Officer	$188K	-$49.1K	-20.7%	Aug 15, 2024
Robert Lechleider	Chief Medical Officer	$150K	+$150K		Nov 21, 2024
Bob Lapetina	PAO and VP Finance & Corporate	$71.2K			Jan 2, 2024
John L. Lamattina	Director				Jun 8, 2023
Purnanand D. Sarma	President and CEO, Director				Jun 8, 2023
Richard A. Baron	Director				Jun 8, 2023
Philip Wagenheim	Director				Jun 13, 2024
Carol Schafer	Director				Jun 13, 2024
Phil Noland Roberts	Chief Technology Officer				Dec 13, 2023
Sandra M. Swain	Director				Jun 13, 2024
Michael Lefenfeld	Director				Jun 8, 2023
Dennis H. Giesing	Chief Development Officer				Jun 8, 2023
Michael Widlitz	Director				May 28, 2021
Corleen Roche	Chief Financial Officer				Jun 8, 2023
Kinney Horn	Chief Business Officer				Aug 9, 2024
Sandra Stoneman	Chief Legal Officer & Gc				Aug 9, 2024
Matthew K. Robinson	Chief Technology Officer				Jun 8, 2023
James P. Boylan	Director				Jun 13, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.